{
    "nctId": "NCT04751201",
    "briefTitle": "Meditation and Cancer, Pilot Feasibility Study (MAEva Pilot Study)",
    "officialTitle": "Meditation and Cancer: Effectiveness of the MAEva Program on Symptoms and Quality of Life. Pilot Feasibility Study. (MAEva Pilot Study)",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer, Prostate Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "SUPPORTIVE_CARE",
    "enrollmentCount": 40,
    "primaryOutcomeMeasure": "Assess the feasibility and acceptability of the MAEva programme to patients in a specialised care facility",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Major patient\n* Patient with non-metastatic prostate or breast cancer\n* Newly diagnosed patients or those undergoing treatment\n* Patient able and willing to follow all study procedures in accordance with the protocol.\n* Patient having understood, signed and dated the consent form.\n* Patient affiliated to the social security system\n* Patient able to remain in a sitting position during the 2-hour session\n\nExclusion Criteria:\n\n* Impossibility to undergo the medical follow-up of the trial for geographical, social or psychological reasons.\n* Presence of an acute psychiatric disorder: depression in acute phase, unstabilised bipolar disorder, psychotic disorders (delusions, hallucinations), etc.\n* Presence of recurrent uncontrolled panic attacks (notably linked to hypochondriac concerns)\n* Presence of latent or patent post-traumatic stress disorder\n* Lack of motivation to meditate\n* Insufficient attentional resources to meditate: major problems with attention, memory or reasoning\n* Patient with metastatic cancer.\n* Presence of cognitive and neurocognitive disorders and deficits\n* Presence of deafness\n* Membership in a meditation programme prior to inclusion",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}